An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations

Nicholas Pulliam, Fang Fang, Ali R. Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B. Baylin, Daniela Matei, Harikrishna Nakshatri, Feyruz V. Rassool, Kathy D. Miller, Kenneth P. Nephew

Research output: Contribution to journalArticle

30 Scopus citations

Fingerprint Dive into the research topics of 'An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences